About Us

  • African biomanufacturer of “best-in-class” molecular biology enzymes.
  • Artificial Intelligence (AI) platform with proprietary machine learning algorithms for development of “best-in-class” enzymes and kits.
  • Highly skilled team of scientists that help clients increase their productivity.

We use our proprietary technology for large scale biomanufacturing of our enzymes and assays.

CapeBio™ Technologies Pty (Ltd) (CapeBio™) with registration number: 2018/505984/07 is a South African biotechnology company that specializes in biomanufacturing of molecular biology enzyme technologies. These products are sourced from rich South African indigenous biodiversity hotspots.

Our enzymes are key drivers and components for molecular diagnostics assays.

We have experience in developing molecular, biotechnology and bioinformatics technologies and their applications.

CapeBio™ is a 100% BBBEE company.

10+

Countries using our products

12

Expert Staff

Vision

We create excellent innovations that improve  the quality of life in Africa and beyond.

Mission

To develop  “best-in-class “life science research enzymes, assays and kits discovered from the rich African indigenous microbial diversity.

Our History

2015

CapeBio™ Initiative

CapeBio™ Initiative is conceptualized and initiated at Council for Scientific and Industrial Research (CSIR) – with the support from Department of Science and Innovation (DSI).

2015

CapeBio™ Initiative

2016

CapeExpress™ DNA ligase

The first flagship product (CapeExpress™ DNA ligase) is launched for market testing. The product is distributed to researchers across South Africa for evaluation and feedback. We also trademarked in different territories.

2016

CapeExpress™ DNA ligase

2017

CapeSprint™ Taq DNA Polymerase

The second flagship product (CapeSprint™ Taq DNA polymerase) enters a market testing phase. It is distributed to the researchers across South Africa, Southern, Western and Eastern Africa.

2017

CapeSprint™ Taq DNA Polymerase

2018

CapeHi-Fidelity™ and Pty (Ltd) Registered

The third product (CapeHi-Fidelity™ Pfu DNA polymerase) enters the market testing phase and distributed to researchers for evaluations and feedback. And CapeBio™ Technologies (Pty) Ltd is officially registered as a private entity.

2018

CapeHi-Fidelity™ and Pty (Ltd) Registered

2019

Funding, Partnerships and Awards

We raised funding with E2 Investments and officially launched the products in the market. While winning 3rd Prize Award at the Africa Start-up Gate Summit in Tunisia and 1st Prize Award in partnership with ARC at the South African Innovation Bridge sponsored by Department of Science and Innovation, Technology Innovation Agency, SEDA and KISCH IP.

2019

Funding, Partnerships and Awards

2020

COVID-19 RT-qPCR test kit

CapeBio™ develops COVID-19 RT-qPCR test kit and associated reagents.

2020

COVID-19 RT-qPCR test kit

2021

Proprietary AI Platform Development Launch

CapeBio™ develops and launches its proprietary AI and machine learning platform for development of "best-in-class" biomolecules for wide range of life science industrial applications.

2021

Proprietary AI Platform Development Launch

Why Choose Us

We create excellent innovations that improve  the quality of life in Africa and beyond.

High Quality Products

Optimized Products

Customized Solutions

Scale-Up Manufacturing

Subscribe To Our Newsletter

Stay in touch with us to get latest news and special offers.

Address

CapeBio™ Technologies (Pty) Ltd Unit 2 Parkside Office Park, 86 Oak Avenue, Highveld Technopark, Centurion, 0157

Call Us

General: +27 (0) 12 665 2600
Sales: +27 (0) 12 665 0422

Email Us

General: info@capebiosa.com
Sales: sales@capebiosa.com
Support: techsupport@capebiosa.com

Scroll to Top